The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Conference at the H R College of Commerce and Economics on The Knowledge Continuum: From Ancient Foundations to Intelligent Futures
Artificial Intelligence can never replace human creativity, Emotional Quotient, wisdom, empathy and understanding. To embrace the new knowledge technologies, we…
LG Unleashes Next-Level Audio Experience with the Latest XBOOM Series
Bengaluru, 28 October 2023 – LG Electronics, one of the leading consumer durable brands in India, today announced the launch…
FITTR kicks off Transformation Challenge 18; participants have 12 weeks to get fit & the best transformations win a sponsored trip to Spain!
India, 11th February 2023: FITTR, India’s leading tech-enabled community-first health and fitness platform, constantly strives to introduce novel initiatives and…
